These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2870294)

  • 1. Beta-lactamase induction and derepression.
    Phillips I
    Lancet; 1986 Apr; 1(8484):801-2. PubMed ID: 2870294
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of beta-lactamases against beta-lactams.
    Stratton CW
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():23-35. PubMed ID: 3062002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics.
    Sanders CC
    Annu Rev Microbiol; 1987; 41():573-93. PubMed ID: 3318679
    [No Abstract]   [Full Text] [Related]  

  • 4. [A bacteriologic study of beta-lactamase-producing organisms--drug resistance and clinical behavior].
    Kim SJ; Tamaki H; Matsuoka K; Kanehiro I
    Nihon Jibiinkoka Gakkai Kaiho; 1988 Nov; 91(11):1883-91. PubMed ID: 3265433
    [No Abstract]   [Full Text] [Related]  

  • 5. Trapping and hydrolysis are not mutually exclusive mechanisms for beta-lactamase-mediated resistance.
    Sanders CC; Sanders WE
    J Antimicrob Chemother; 1986 Jan; 17(1):121-2. PubMed ID: 3485090
    [No Abstract]   [Full Text] [Related]  

  • 6. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting the challenges of beta-lactamases.
    Moellering RC
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():1-8. PubMed ID: 8449834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
    Mouton RP; Bongaerts GP; van Gestel MH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible beta-lactamases and non-hydrolytic resistance mechanisms.
    Sanders CC
    J Antimicrob Chemother; 1984 Jan; 13(1):1-3. PubMed ID: 6607915
    [No Abstract]   [Full Text] [Related]  

  • 10. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-lactamase inhibitors].
    Nishiya H; Kunii O
    Nihon Rinsho; 1991 Sep; 49(9):2046-51. PubMed ID: 1960873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and laboratory significance of inducible beta-lactamases].
    Bedenić B; Zagar Z
    Lijec Vjesn; 1995; 117(9-10):249-53. PubMed ID: 8643019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():103-10. PubMed ID: 6976960
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of beta-lactamases.
    Eliopoulos GM
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():37-44. PubMed ID: 3062003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of faropenem against beta-lactamase producing clinical isolates].
    Nishiyama T; Matsuzaki K; Koyama H; Saika T; Hasegawa M; Kobayashi I
    Jpn J Antibiot; 2000 Mar; 53(3):179-83. PubMed ID: 10834149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability.
    Stobberingh EE; Houben AW; van Boven CP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():73-83. PubMed ID: 3875605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial resistance to antibiotics: biologic and ecologic aspects].
    Cavallo G
    G Batteriol Virol Immunol; 1988; 81(1-12):96-116. PubMed ID: 3079150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sch 29482: stability and inhibitory potency towards beta-lactamases from Gram-negative bacteria.
    Pechère JC; Letarte R; Guay R; Asselin C; Morin C
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():123-32. PubMed ID: 6977528
    [No Abstract]   [Full Text] [Related]  

  • 19. Test for beta-lactamase production.
    Weinbren MJ; Perinpanayagam RM
    Lancet; 1985 Sep; 2(8456):673-4. PubMed ID: 2863667
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of beta-lactamases in Africa: correlation with resistance to beta-lactam antibiotics.
    Dowse LJ; Prigent BM
    Clin Ther; 1991; 13(2):243-53. PubMed ID: 1863940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.